Sign Out
Pregnancy: There are no or limited amount of data from the use of ophthalmic olopatadine in pregnant women.
Olopatadine is not recommended during pregnancy and in women of childbearing potential not using contraception.
Breast-feeding: Available data in animals have shown excretion of olopatadine in milk following oral administration.
A risk to the newborn/infants cannot be excluded.
Olopatadine should not be used during breast-feeding.
Fertility: Studies have not been performed to evaluate the effect of topical ocular administration of olopatadine on human fertility.
Continue with Google